Daiwa Securities Group
NRC icon

Daiwa Securities Group’s NRC Health Common Stock NRC Stock Holding History

Daiwa Securities Group’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629K Buy
29,171
+9,335
+47% +$173K ﹤0.01% 931
2026
Q1 		$337K Sell
19,836
-2,400
-11% -$40.8K ﹤0.01% 966
2025
Q4 		$417K Sell
22,236
-2,875
-11% -$43.4K ﹤0.01% 926
2025
Q3 		$321K Sell
25,111
-857
-3% -$12.9K ﹤0.01% 942
2025
Q2 		$436K Sell
25,968
-5,000
-16% -$67.5K ﹤0.01% 889
2025
Q1 		$396K Sell
30,968
-2,000
-6% -$32.1K ﹤0.01% 872
2024
Q4 		$582K Hold
32,968
– – ﹤0.01% 809
2024
Q3 		$754K Sell
32,968
-4,500
-12% -$102K ﹤0.01% 777
2024
Q2 		$860K Sell
37,468
-1,200
-3% -$37K ﹤0.01% 739
2024
Q1 		$1.53M Buy
38,668
+4,350
+13% +$172K 0.01% 618
2023
Q4 		$1.36M Sell
34,318
-5,300
-13% -$222K 0.01% 618
2023
Q3 		$1.76M Sell
39,618
-6,084
-13% -$265K 0.01% 529
2023
Q2 		$1.99M Sell
45,702
-2,800
-6% -$123K 0.01% 501
2023
Q1 		$2.11M Sell
48,502
-4,300
-8% -$190K 0.01% 477
2022
Q4 		$1.97M Sell
52,802
-3,000
-5% -$116K 0.02% 483
2022
Q3 		$2.22M Sell
55,802
-8,000
-13% -$296K 0.02% 430
2022
Q2 		$2.44M Sell
63,802
-5,000
-7% -$181K 0.02% 404
2022
Q1 		$2.73M Hold
68,802
– – 0.02% 413
2021
Q4 		$2.86M Hold
68,802
– – 0.02% 407
2021
Q3 		$2.9M Buy
68,802
+9,000
+15% +$453K 0.02% 383
2021
Q2 		$2.75M Buy
59,802
+14,200
+31% +$675K 0.02% 374
2021
Q1 		$2.14M Sell
45,602
-17,200
-27% -$836K 0.02% 401
2020
Q4 		$2.69M Buy
62,802
+2,702
+4% +$139K 0.02% 324
2020
Q3 		$2.96M Buy
60,100
+15,554
+35% +$861K 0.03% 255
2020
Q2 		$2.03M Hold
44,546
– – 0.04% 227
2020
Q1 		$2.03M Buy
44,546
+24,346
+121% +$1.46M 0.02% 315
2019
Q4 		$1.33M Buy
+20,200
New +$1.23M 0.01% 444

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Daiwa Securities Group's NRC Position: Q2 2026 in Review

Daiwa Securities Group increased its NRC Health Common Stock (NRC) stake by 47% in Q2 2026, buying an estimated $173K and bringing the position to 29,171 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Daiwa Securities Group first reported a position in NRC in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.96M in Q3 2020. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • Daiwa Securities Group held 29,171 shares of NRC Health Common Stock worth $629K as of Q2 2026.
  • Daiwa Securities Group bought 9,335 NRC Health Common Stock shares in Q2 2026, an estimated $173K.
  • NRC Health Common Stock made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #931 holding.
  • Daiwa Securities Group first reported a position in NRC Health Common Stock in Q4 2019 and has held it in 27 quarters since.
  • Daiwa Securities Group's NRC Health Common Stock position peaked at $2.96M in Q3 2020.
  • 124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.